Journal of Bone Oncology

Papers
(The median citation count of Journal of Bone Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation53
Fracture risk in breast cancer: Does obesity have an effect? A scoping review44
Langerhans Cell Histiocytosis: A Population-based Study of Anatomical Distribution and Treatment Patterns36
Discharge status and post-discharge healthcare costs after skeletal-related event hospitalizations among medicare patients with bone metastatic solid tumors or multiple myeloma32
Bones and guts – Why the microbiome matters30
Role of the osteocyte in bone metastasis – The importance of networking28
Macrophage heterogeneity in bone metastasis26
Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis24
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms22
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors22
Prosthesis or osteosynthesis for the treatment of a pathological hip fracture? A nationwide registry-based cohort study19
Prognostic factors and survival of patients undergoing surgical intervention for breast cancer bone metastases18
Deep learning-based magnetic resonance imaging of the spine in the diagnosis and physiological evaluation of spinal metastases18
The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study)18
Automated measurement of lumbar pedicle screw parameters using deep learning algorithm on preoperative CT scans18
Study of imaging changes following preoperative denosumab for giant cell tumor of bone17
Emerging roles for stromal cells in bone metastasis17
Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression16
#21. PD-1 blockade induces bone loss and reduces bone strength in a breast cancer bone metastasis model16
#9. Inhibition of the fatty acid binding proteins (FABPs) in myeloma cells modifies their lipid composition15
Long non-coding RNA KRT8P41/miR-193a-3p/FUBP1 axis modulates the proliferation and invasion of chordoma cells15
#45. Fatty acid binding proteins may modulate myeloma in Fabp4/5 double knockout mouse15
#37. Lactate-GPR81 signaling in acute myeloid leukemia (AML) contributes to bone marrow microenvironment dysfunction, macrophage polarization, and leukemia cell growth15
#43. Long-chain acyl-CoA synthetases support multiple myeloma cell proliferation, survival and mitochondrial function14
#33. PTHrP biological domains differentially regulate breast tumor intracrine signaling independent of nuclear localization14
#15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma13
#7. Downstream effects of Gli2 targeting on tumor-immune cell crosstalk in bone metastatic breast cancer13
#42. Local and systemic effects of Dickkopf-1 during breast cancer progression by limiting NK cell-mediated killing13
CDK4/6 inhibitor and doxorubicin synergistically inhibit breast cancer bone metastasis and enhance T-cell targeted therapy13
Incidence, Risk Factors, and Survival of Bone Metastases and Skeletal-Related Events in Melanoma Patients: A Systematic Review and Quality Assessment of 29 Studies12
Automatic classification of spinal osteosarcoma and giant cell tumor of bone using optimized DenseNet12
Targeting ferroptosis in osteosarcoma12
Preventing osteolytic lesions and osteomyelitis in multiple myeloma12
What to choose in bone tumour resections? Patient specific instrumentation versus surgical navigation: a systematic review12
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States11
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma11
Targeting transforming growth factor beta signaling in metastatic osteosarcoma11
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval11
Surgical management and outcome of Extra-adrenal myelolipomas at unusual locations: A report of 11 cases in a single center11
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring mod10
Postoperative outcomes of subaxial cervical spine metastasis: Comparison among the anterior, posterior, and combined approaches10
YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD52210
Bone tumor examination based on FCNN-4s and CRF fine segmentation fusion algorithm10
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p10
Adamantinoma: A review of the current literature10
Osteoblasts derived from mouse mandible enhance tumor growth of prostate cancer more than osteoblasts derived from long bone10
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?10
Erratum to “Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma” [J. Bone Oncol. 26 (2021) 100331]9
The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma9
Impact of quantitative CT texture analysis on the outcome of CT-guided bone biopsy9
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw9
Sensory nerves: A driver of the vicious cycle in bone metastasis?9
Is surgery without curettage effective for periacetabular Metastasis? Insights from a survival study of 93 patients9
Urinary biomarkers in metastatic bone pain: Results from a multicentre randomized trial of ibandronate compared to single dose radiotherapy for localized metastatic bone pain in prostate cancer (RIB)8
State-of-the-art of minimally invasive treatments of bone metastases8
N-cadherin in osteolineage cells modulates stromal support of tumor growth8
Bone niches in the regulation of tumour cell dormancy8
Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study8
Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review8
Phenotypic plasticity – Implications for tumours in bone8
Silencing of circCYP51A1 represses cell progression and glycolysis by regulating miR-490-3p/KLF12 axis in osteosarcoma under hypoxia8
Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway8
Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner8
Does liquid nitrogen recycled autograft for treatment of bone sarcoma impact local recurrence rate? A systematic review7
Establishment and characterization of a highly metastatic human osteosarcoma cell line from osteosarcoma lung metastases7
Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix7
The patterns of distant metastasis and prognostic factors in patients with primary metastatic Ewing sarcoma of the bone7
Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis7
LINC00482 sponged miR-2467-3p to promote bone metastasis of prostate cancer through activating Wnt/β-catenin signaling pathway7
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation7
Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axis7
Adipocytes and metabolism: Contributions to multiple myeloma7
In vitro three-dimensional cell cultures for bone sarcomas6
#35. Defining short-form RON mediated anti-tumor immunity in breast cancer bone metastasis6
#3. IL-17A supports osteoblasts to become cancer-associated fibroblasts in breast cancer bone metastases6
#10. Investigating the role of non-canonical Hedgehog signaling in paclitaxel-resistant bone- metastatic breast cancer6
Bone-derived excess TGF-ß release is associated with cognitive dysfunction due to oxidation of RyR, Ca2+ leak and mitochondrial dysfunction6
#17. Evolution of epidemiology of bone metastasis in France: A rising issue6
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical pr6
Deep bone oncology Diagnostics: Computed tomography based Machine learning for detection of bone tumors from breast cancer metastasis6
#36. Novel therapeutic development with serine biosynthesis inhibition and molecularly targeted drugs against the aggressive osteosarcoma6
#5. Activating RET mutations in medullary thyroid cancer cells promotes osteoblastic bone metastasis by inhibiting osteoclastogenesis and stimulating osteoblast activity6
Contrast-enhanced magnetic resonance image segmentation based on improved U-Net and Inception-ResNet in the diagnosis of spinal metastases6
Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?5
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-3845
Prevalence of low bone mineral density and risk of fractures in osteosarcoma and Ewing’s sarcoma survivors: A scoping review5
Commentary: A Special Edition in bone sarcoma5
Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer5
RNA 5-methylcytosine status is associated with DNMT2/TRDMT1 nuclear localization in osteosarcoma cell lines5
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results5
Epidemiology and detection of cement leakage in patients with spine metastases treated with percutaneous vertebroplasty: A 10-year observational study5
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer5
Non-POEMS osteosclerotic multiple myeloma: Clinical characteristics and differential diagnosis5
A novel adjunctive diagnostic method for bone cancer: Osteosarcoma cell segmentation based on Twin Swin Transformer with multi-scale feature fusion5
The role of intraoperative cell salvage for musculoskeletal sarcoma surgery5
Current strategies for the treatment of solitary and aneurysmal bone cysts: A review of the literature5
Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review5
Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data5
MUTARS® Humero pro Femur replacement: A novel reconstructive procedure after malignant bone tumor resection of the femur in young children5
The osteoblast in regulation of tumor cell dormancy and bone metastasis4
Prosthetic reconstruction following resection of lower extremity bone neoplasms: A systematic review and meta-analysis4
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer4
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations4
Frequency and reason for reoperation following non-invasive expandable endoprostheses: A systematic review4
New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma4
Appendicular dedifferentiated chondrosarcoma: A management and survival study from the SEER database4
Separation surgery followed by stereotactic ablative radiotherapy for metastatic epidural spinal cord compression: A systematic review and meta-analysis for local progression rate4
Neurological outcomes after surgery for spinal metastases in symptomatic patients: Does the type of decompression play a role? A comparison between different strategies in a 10-year experience4
FBXO22 is a potential therapeutic target for recurrent chondrosarcoma4
Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response4
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer4
Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors4
#38. Cholesterol increases bone marrow tumour burden in myeloma in vivo and promotes myeloma cell viability and bortezomib resistance ex vivo3
#39. Bone-derived Dickkopf-related protein 1 supports primary breast cancer growth and alters hematopoiesis3
#44. A novel osteolineage-derived (Osterix+) stromal population contributes to breast cancer progression3
#32. Identification of proteins regulating the metastatic spread of breast cancer to bone: Proteomic analysis of the role of the pro-metastatic transcription factor TWIST1 and the gene target micro-RN3
Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study3
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study3
#27. First-in-human evaluation of safety and dosimetry of 64Cu-LLP2A for PET imaging3
#41. Discovery of novel tubulin code in bone metastasis of breast cancer3
BoHFAB. The impact of adjuvant zoledronate therapy on bone health in postmenopausal patients with early breast cancer3
#18. Inhibition of de novo serine synthesis in osteosarcoma depletes cysteine and drives dependency upon exogenous cystine import through system xCT to maintain redox balance3
All bone metastases are not created equal: Revisiting treatment resistance in renal cell carcinoma3
Circular RNA circANKIB1 promotes the progression of osteosarcoma by regulating miR-217/PAX3 axis3
Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefits3
#19. RANKL independent osteolysis in Adult T cell leukemia via small extracellular vesicles3
MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway3
#1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma3
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE3
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study3
Adoption of adjuvant bisphosphonates for early breast cancer into standard clinical practice: Challenges and lessons learnt from comparison of the UK and Australian experience3
#53. Limiting metastatic breast cancer progression by targeting MK2 stromal signaling3
Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord2
Diagnostic value of H3F3A mutation and clinicopathological features of giant cell tumours in non-long bones2
-AI-assisted diagnostic potential of CT in bone oncology and its impact on clinical decision-making for intensive care2
Clinical decision-making in bone cancer care management and forecast of ICU needs based on computed tomography2
Radiomics analysis of thoracic vertebral bone marrow microenvironment changes before bone metastasis of breast cancer based on chest CT2
Malignancy in giant cell tumor of bone in the extremities2
Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers2
AI based diagnostics product design for osteosarcoma cells microscopy imaging of bone cancer patients using CA-MobileNet V32
Bone metastases from urothelial carcinoma. The dark side of the moon2
Surgical Options for Aggressive Vertebral Hemangiomas:A case series, literature review and treatment recommendations2
Bone density measurement in patients with spinal metastatic tumors using chest quantitative CT deep learning model2
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors2
Efficacy of replacing actinomycin-D with carboplatin in Ewing sarcoma consolidation treatment: Single-center experience2
FGF-23 transmitted tumor – induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature2
BAIAP2L2 promotes the proliferation, migration and invasion of osteosarcoma associated with the Wnt/β-catenin pathway2
Automated segmentation and source prediction of bone tumors using ConvNeXtv2 Fusion based Mask R-CNN to identify lung cancer metastasis2
Deep hashing and attention mechanism-based image retrieval of osteosarcoma scans for diagnosis of bone cancer2
Out with the old (not so!) and in with the new2
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin2
Epigenetic control of the vicious cycle2
Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations1
Trends in primary malignant bone cancer incidence and mortality in the United States, 2000–2017: A population-based study1
Let-7a suppresses Ewing sarcoma CSCs’ malignant phenotype via forming a positive feedback circuit with STAT3 and lin281
#6. Mechanical loading of breast cancer laden bones alters osteocyte mediated bone loss in vivo1
#52. Computational modeling of signaling pathways and cell-cell interactions driving tumor-induced bone disease1
Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma1
Chemotherapy-induced adipocyte senescence triggers bone loss through RANKL-mediated osteoclastogenesis1
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review1
A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva®) in healthy Chinese subjects1
Implant failure and revision strategies after total spondylectomy for spinal tumors1
Imaging evaluation of blood supply changes after chemotherapy of osteosarcoma and its correlation with tumor necrosis rate1
The role of mitochondria-related lncRNAs in characterizing the immune landscape and supervising the prognosis of osteosarcoma1
Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment1
#2. Homing of intestinal NK and Th1 cells to the tumor site restrains melanoma bone growth in a gut microbiome dependent manner1
#49. Complete estrogen-deprived athymic nude mice are susceptible to changes in metabolism and musculoskeletal function mediated by a high-fat diet1
PTHrP biological domains mediate breast cancer bone osteolysis via TGF-β/SNAI2/ZEB1 pathways1
#20. Investigating the response of prostate cancer cells to bone-derived growth factor gradients via fluid-wall microfluidic culture systems1
Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma1
DXA assessment and fracture prevention in hormone positive breast cancer patients after treatment initiation with aromatase inhibitors: A registry-based cohort study1
A fusion of VGG-16 and ViT models for improving bone tumor classification in computed tomography1
#28. Identification of key proteins within prostate cancer derived exosomes and their role in priming the pre-metastatic niche1
The role of IL-1B in breast cancer bone metastasis1
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways1
#4. Elucidating the effect of glutamine metabolism in breast-to-bone metastasis1
#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone1
#24. Mechanical loading-induced changes to the bone microenvironment control bone metastatic breast cancer lesions1
#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER1
Primary perivascular epithelioid cell tumor (PEComa) in bone: A review of the literature and a case arising in the humerus with multiple metastases1
A global bibliometric and visualized analysis of the status and trends of bone metastasis in breast cancer research from 2002 to 20211
#34. The effect of dickkopf-1 (DKK-1) on prostate cancer growth and bone metastasis using the canine osteoblastic Probasco cell line1
0.069872856140137